Cargando…

Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology

The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2–driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Walzl, Gerhard, Tafuro, Sabrina, Moss, Paul, Openshaw, Peter J.M., Hussell, Tracy
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193356/
https://www.ncbi.nlm.nih.gov/pubmed/11067880
_version_ 1782147451577171968
author Walzl, Gerhard
Tafuro, Sabrina
Moss, Paul
Openshaw, Peter J.M.
Hussell, Tracy
author_facet Walzl, Gerhard
Tafuro, Sabrina
Moss, Paul
Openshaw, Peter J.M.
Hussell, Tracy
author_sort Walzl, Gerhard
collection PubMed
description The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2–driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that previous influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated role in subsequent vaccination and infection. The data have important implications for the timing of vaccinations in certain patient groups, and may contribute to variability in disease susceptibility observed in humans.
format Text
id pubmed-2193356
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21933562008-04-16 Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology Walzl, Gerhard Tafuro, Sabrina Moss, Paul Openshaw, Peter J.M. Hussell, Tracy J Exp Med Original Article The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2–driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that previous influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated role in subsequent vaccination and infection. The data have important implications for the timing of vaccinations in certain patient groups, and may contribute to variability in disease susceptibility observed in humans. The Rockefeller University Press 2000-11-06 /pmc/articles/PMC2193356/ /pubmed/11067880 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Walzl, Gerhard
Tafuro, Sabrina
Moss, Paul
Openshaw, Peter J.M.
Hussell, Tracy
Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title_full Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title_fullStr Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title_full_unstemmed Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title_short Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
title_sort influenza virus lung infection protects from respiratory syncytial virus–induced immunopathology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193356/
https://www.ncbi.nlm.nih.gov/pubmed/11067880
work_keys_str_mv AT walzlgerhard influenzaviruslunginfectionprotectsfromrespiratorysyncytialvirusinducedimmunopathology
AT tafurosabrina influenzaviruslunginfectionprotectsfromrespiratorysyncytialvirusinducedimmunopathology
AT mosspaul influenzaviruslunginfectionprotectsfromrespiratorysyncytialvirusinducedimmunopathology
AT openshawpeterjm influenzaviruslunginfectionprotectsfromrespiratorysyncytialvirusinducedimmunopathology
AT husselltracy influenzaviruslunginfectionprotectsfromrespiratorysyncytialvirusinducedimmunopathology